Clinical Trial Detail

NCT ID NCT03416179
Title A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia (BRIGHT AML1019)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Pfizer
Indications

acute myeloid leukemia

Therapies

Cytarabine

Cytarabine + Daunorubicin + Glasdegib

Azacitidine + Glasdegib

Azacitidine

Cytarabine + Daunorubicin

Age Groups: senior adult

No variant requirements are available.